- Home
- WK vs ICUI Comparison
WK vs ICUI Comparison
Compare WK & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WK | ICUI |
|---|---|---|
| Founded | 2008 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.5B |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | WK | ICUI |
|---|---|---|
| Price | $47.04 | $139.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $95.30 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 831.7K | 251.3K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 52.53 | ★ 100.62 |
| EPS | 0.33 | ★ 1.20 |
| Revenue | $884,568,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $20.85 | N/A |
| Revenue Next Year | $15.43 | $4.46 |
| P/E Ratio | $144.98 | ★ $114.95 |
| Revenue Growth | ★ 19.75 | N/A |
| 52 Week Low | $43.34 | $107.02 |
| 52 Week High | $97.10 | $160.29 |
Technical Indicators
Market Signals| Indicator | WK | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 40.15 | 57.77 |
| Support Level | $46.65 | $115.74 |
| Resistance Level | $53.06 | $142.31 |
| Average True Range (ATR) | 2.23 | 4.13 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 7.51 | 65.49 |
Price Performance
Historical ComparisonAbout WK Workiva Inc.
Workiva Inc is an AI-powered platform for trust, transparency, and accountability. Accounting, finance, sustainability, risk, and audit teams rely on Workiva for their mission-critical work. It transforms how customers connect data, unify processes, and empower teams in a secure, AI-powered, audit-ready, collaborative platform. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.